Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07332923

Predicting HIF-2α Levels in Clear Cell Kidney Cancer Using Machine Learning

Sponsor: First Affiliated Hospital of Fujian Medical University

View on ClinicalTrials.gov

Summary

This project aims to conduct a multicenter retrospective study to collect clinical, CT imaging, and pathological data from patients. A comprehensive data management system will be established, and radiomic features will be extracted to integrate and analyze multicenter data. We will develop a predictive model based on CT radiomic features and perform both internal and external cohort validation. The model will predict HIF-2α expression levels and clinically relevant prognostic factors in ccRCC, enabling precise identification of patient populations responsive to the HIF-2α antagonist Belzutifan, thereby facilitating personalized treatment decisions, minimizing unnecessary therapeutic risks, and ultimately improving patient quality of life and clinical outcomes.

Official title: Development of a Machine Learning-Based Nomogram for Predicting HIF-2α Expression Levels in Clear Cell Renal Cell Carcinoma

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

500

Start Date

2024-08-01

Completion Date

2026-09-01

Last Updated

2026-01-12

Healthy Volunteers

No

Locations (1)

first hospital affiliated of Fujian medical university

Fuzhou, Fujian, China